Presenter
Orin Levine, Non-Resident Fellow, Center for Global Development
Featuring
Johannes Ahrendts, Director, Strategy, Funding and Performance, Gavi, the Vaccine Alliance
Gabriella Fésüs, Head of Unit for Social Inclusion & Protection, Health and Demography, Directorate-General for International Partnerships, European Commission
Shanelle Hall, Founder, The Yellow House
Justice Nonvignon, Head, Health Economics Programme, Africa Centres for Disease Control and Prevention; Non-Resident Fellow, Center for Global Development
Kate O’Brien, Director, Department of Immunization, Vaccines and Biologicals, World Health Organization
Moderator
Janeen Madan Keller, Deputy Director of Global Health Policy and Policy Fellow, Center for Global Development
2024 is a pivotal year for Gavi, the Vaccine Alliance as it formulates a new strategy to inform its next investment case and replenishment cycle—and a new CEO takes the helm.
Gavi has made significant progress in expanding access to immunization and averting millions of deaths from vaccine-preventable diseases. But disruptions on the horizon are exerting pressure on its ability to deliver results in a rapidly shifting global landscape. The 2026-2030 strategic period, known as “Gavi 6.0,” offers a critical window to leverage Gavi’s strengths and mitigate impacts of disruptions.
Join CGD for a virtual discussion, building on new research and analyses, to examine how Gavi can adopt a new playbook to maximize impact and remain fit-for-purpose in an evolving global landscape.
